Aberdeen Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,287	Closed	-$662K	–	984
2020 Q3	$662K	Buy	+10,287	New	+$662K	﹤0.01%	838
2018 Q2	–	Sell	-33,732	Closed	-$322K	–	921
2018 Q1	$322K	Buy	+33,732	New	+$322K	﹤0.01%	780